Is Dolby Laboratories (DLB) Offering Value After Recent Share Price Pullback

• If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in.
• The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years.
• Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader software and media ecosystems. This gives context to the share price weakness over multiple time frames, as investors are weighing up how its licensing model and technology adoption trends compare with other software names while sentiment has cooled.
• On Simply Wall St's valuation framework Dolby scores a full 6 out of 6 on undervaluation checks. The next step is to look at how different valuation approaches line up on the stock and then consider an even richer way to think about value that ties them all together.

Find out why Dolby Laboratories's -25.9% return over the last year is lagging behind its peers.

Approach 1: Dolby Laboratories Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company could be worth today by projecting its future cash flows and discounting them back to the present. It is essentially asking what all those future dollars are worth in today’s terms.

For Dolby Laboratories, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about $386.6 million. Based on analyst inputs and further extrapolation by Simply Wall St, free cash flow is projected to reach about $752.3 million in 2035, with intermediate years such as 2026 and 2028 at $412.9 million and $548.0 million respectively.

Discounting this stream of projected cash flows in dollars back to today produces an estimated intrinsic value of $111.85 per share. Compared to the current share price around $58, the model implies the stock trades at a 48.1% discount, which indicates Dolby is materially undervalued on this DCF view.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Dolby Laboratories is undervalued by 48.1%. Track this in your watchlist or portfolio, or discover 60 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Dolby Laboratories.

Approach 2: Dolby Laboratories Price vs Earnings

For a profitable company like Dolby Laboratories, the P/E ratio is a useful way to gauge what you are paying for each dollar of earnings. Higher growth expectations or lower perceived risk can justify a higher P/E, while slower growth or higher risk usually lines up with a lower, more conservative multiple.

Dolby currently trades on a P/E of 23.1x. That sits below the broader Software industry average P/E of about 28.5x and also below the peer group average of 24.4x. On simple comparisons, the stock is priced at a discount to both its sector and closer peers.

Simply Wall St’s Fair Ratio for Dolby is 23.8x. This is a proprietary estimate of what a “normal” P/E could be for the company, based on factors like its earnings growth profile, profit margins, industry, market cap and specific risks. Because it is tailored to Dolby’s characteristics rather than broad group averages, the Fair Ratio can give a more focused read on whether the current market pricing looks stretched or conservative.

With the actual P/E of 23.1x sitting slightly below the Fair Ratio of 23.8x, Dolby’s price looks mildly discounted using this approach.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Dolby Laboratories Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives bring that idea to life by letting you attach a clear story about Dolby Laboratories to the numbers you see, linking your view of its future revenue, earnings and margins to a Fair Value that can be compared with the current price.

On Simply Wall St's Community page, Narratives are easy to use and update automatically when fresh information such as news, guidance or earnings is added. This means your Fair Value view does not sit still while the company moves.

For Dolby, one investor might build a more optimistic Narrative that lines up with a Fair Value around US$90 per share, while another might prefer a more cautious Narrative closer to US$68. By comparing each Narrative's Fair Value with the live market price you can decide whether you see Dolby as closer to an opportunity or already fairly priced.

Do you think there's more to the story for Dolby Laboratories? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com